Status:
COMPLETED
Extension Study for Participants of MACI00206 Study of MACI® for the Treatment of Symptomatic Articular Cartilage Defects of the Knee
Lead Sponsor:
Vericel Corporation
Conditions:
Articular Cartilage Defects
Eligibility:
All Genders
18-55 years
Brief Summary
To examine the 5-year efficacy and safety of MACI implant, compared with arthroscopic microfracture, in participants who received study treatment in the SUMMIT study for treatment of symptomatic artic...
Detailed Description
This study was an open-label, multicenter extension to the SUMMIT study designed to examine the 5-year efficacy and safety of MACI compared to arthroscopic microfracture in the treatment of articular ...
Eligibility Criteria
Inclusion
- Randomized and received study treatment (MACI or microfracture) in the SUMMIT study.
Exclusion
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT01251588
Start Date
December 1 2010
End Date
March 1 2015
Last Update
May 12 2021
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Urazova nemocnice v Brne
Brno, Czechia, 662 50
2
University Hospital Na Bulovce- Department of Orthopaedic Surgery Postgraduate Medical Institute
Prague, Czechia, 180 81
3
Polyclinique Saint-Roch
Montpellier, France, 34967
4
Clinique Maussins-Nollet
Paris, France, 75019